BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoeltzenbein M, Beck E, Rajwanshi R, Gøtestam Skorpen C, Berber E, Schaefer C, Østensen M. Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data. Seminars in Arthritis and Rheumatism 2016;46:238-45. [DOI: 10.1016/j.semarthrit.2016.05.004] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Giles I, Yee C, Gordon C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol 2019;15:391-402. [DOI: 10.1038/s41584-019-0240-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
2 Wiese MD, Berry MJ, Hissaria P, Darby JRT, Morrison JL. COVID-19: can we treat the mother without harming her baby? J Dev Orig Health Dis 2021;:1-11. [PMID: 33487213 DOI: 10.1017/S2040174420001403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø. Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. J Neurol 2020. [PMID: 33011853 DOI: 10.1007/s00415-020-10235-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Oliva M, Hsu K, Alsamarai S, Chavez V, Ferrara L. Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery. BMJ Case Rep 2020;13:e236290. [PMID: 32675129 DOI: 10.1136/bcr-2020-236290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
5 Czeresnia RM, Trad ATA, Britto ISW, Negrini R, Nomura ML, Pires P, Costa FDS, Nomura RMY, Ruano R. SARS-CoV-2 and Pregnancy: A Review of the Facts. Rev Bras Ginecol Obstet 2020;42:562-8. [PMID: 32992359 DOI: 10.1055/s-0040-1715137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Soh MC, Moretto M. The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy. Obstet Med 2020;13:5-13. [PMID: 32284726 DOI: 10.1177/1753495X19841799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Akioka S. Interleukin-6 in juvenile idiopathic arthritis. Mod Rheumatol 2019;29:275-86. [PMID: 30686091 DOI: 10.1080/14397595.2019.1574697] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
8 Ormaechea MS, Hassan M, Onghanseng N, Park JH, Mahajan S, Al-Kirwi KY, Uludag G, Halim MS, Schlaen A, Sepah YJ, Do DV, Nguyen QD. Safety of systemic therapy for noninfectious uveitis. Expert Opin Drug Saf 2019;18:1219-35. [PMID: 31801415 DOI: 10.1080/14740338.2019.1692810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Balbi GGM, Domingues V, Balbi GGM, De Jesús GR, Levy RA. Use of synthetic and biologic DMARDs during pregnancy. Expert Rev Clin Immunol 2019;15:27-39. [PMID: 30365902 DOI: 10.1080/1744666X.2019.1541739] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lambelet V, Vouga M, Pomar L, Favre G, Gerbier E, Panchaud A, Baud D. SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care. Prenat Diagn 2020;40:1641-54. [PMID: 32453451 DOI: 10.1002/pd.5759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Saito J, Yakuwa N, Kaneko K, Goto M, Kawasaki H, Hamamachi Y, Suzuki T, Sago H, Yamatani A, Murashima A. Tocilizumab drug levels during pregnancy and lactation: A woman who discontinued tocilizumab therapy until the end of the first trimester and resumed it after birth. Obstet Med 2021;14:260-2. [PMID: 34880942 DOI: 10.1177/1753495X20966094] [Reference Citation Analysis]
12 Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019. Am J Obstet Gynecol MFM 2020;2:100159. [PMID: 32838264 DOI: 10.1016/j.ajogmf.2020.100159] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
13 Favilli A, Mattei Gentili M, Raspa F, Giardina I, Parazzini F, Vitagliano A, Borisova AV, Gerli S. Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review. J Matern Fetal Neonatal Med 2020;:1-14. [PMID: 32508168 DOI: 10.1080/14767058.2020.1774875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Jorgensen SCJ, Lapinsky SE. Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review. Clin Microbiol Infect 2021:S1198-743X(21)00476-6. [PMID: 34438068 DOI: 10.1016/j.cmi.2021.08.016] [Reference Citation Analysis]
15 Henson LJ, Afsar S, Davenport L, Purvis A, Poole EM, Truffinet P. Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide. Reprod Toxicol 2020;95:45-50. [PMID: 32407881 DOI: 10.1016/j.reprotox.2020.04.073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Morel J, Tournadre A, Sellam J, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C. Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105221. [PMID: 34183155 DOI: 10.1016/j.jbspin.2021.105221] [Reference Citation Analysis]
17 Moriyama M, Wada Y, Minamoto T, Kondo M, Honda M, Murakawa Y. Unexpectedly lower proportion of placental transferred tocilizumab relative to whole immunoglobulin G: a case report. Scand J Rheumatol 2020;49:165-6. [PMID: 31436129 DOI: 10.1080/03009742.2019.1639821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Abdullah S, Bashir N, Mahmood N. Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports. J Med Case Rep 2021;15:426. [PMID: 34364393 DOI: 10.1186/s13256-021-03010-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Translating IL-6 biology into effective treatments. Nat Rev Rheumatol 2020;16:335-45. [PMID: 32327746 DOI: 10.1038/s41584-020-0419-z] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 48.5] [Reference Citation Analysis]
20 Ghalandari N, Dolhain RJEM, Hazes JMW, van Puijenbroek EP, Kapur M, Crijns HJMJ. Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Drugs 2020;80:1699-722. [PMID: 32852745 DOI: 10.1007/s40265-020-01376-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Borisow N, Hellwig K, Paul F. Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies. EPMA J 2018;9:249-56. [PMID: 30174761 DOI: 10.1007/s13167-018-0143-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
22 Jones G, Panova E. New insights and long-term safety of tocilizumab in rheumatoid arthritis. Ther Adv Musculoskelet Dis 2018;10:195-9. [PMID: 30327685 DOI: 10.1177/1759720X18798462] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Jara LJ, Cruz-Dominguez MDP, Saavedra MA. Impact of infections in autoimmune rheumatic diseases and pregnancy. Curr Opin Rheumatol 2019;31:546-52. [PMID: 31169546 DOI: 10.1097/BOR.0000000000000636] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Barrett JS. Risk assessment of therapeutic agents under consideration to treat COVID-19 in paediatric patients and pregnant women. Br J Clin Pharmacol 2021;87:3462-80. [PMID: 33125791 DOI: 10.1111/bcp.14630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Micu M, Ostensen M, Villiger P, Micu R, Ionescu R. Paternal exposure to antirheumatic drugs—What physicians should know: Review of the literature. Seminars in Arthritis and Rheumatism 2018;48:343-55. [DOI: 10.1016/j.semarthrit.2018.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
26 Lat TI, Patel CD, Ehrig JC, Moslander C, Sanchez JF. Therapeutic options in the treatment of severe acute respiratory syndrome coronavirus 2 in pregnant patient. Am J Obstet Gynecol MFM 2020;2:100224. [PMID: 32954247 DOI: 10.1016/j.ajogmf.2020.100224] [Reference Citation Analysis]
27 Borisow N, Hellwig K, Paul F. [Neuromyelitis optica spectrum disorder and pregnancy]. Nervenarzt 2018;89:666-73. [PMID: 29383411 DOI: 10.1007/s00115-018-0486-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Giampreti A, Eleftheriou G, Gallo M, Butera R, Contessa G, Faraoni L, Sangiovanni A, Negri G, Falchi G, Bacis G. Medications prescriptions in COVID-19 pregnant and lactating women: the Bergamo Teratology Information Service experience during COVID-19 outbreak in Italy. J Perinat Med 2020;48:1001-7. [PMID: 33055313 DOI: 10.1515/jpm-2020-0339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Carnovale C, Parisi F, Battini V, Zavatta A, Cheli S, Cattaneo D, Gringeri M, Mosini G, Guarnieri G, Cammarata G, Cetin I. The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacol Res 2021;171:105786. [PMID: 34314858 DOI: 10.1016/j.phrs.2021.105786] [Reference Citation Analysis]
30 Rodríguez S, Muñoz A, Bustos RH, Jaimes D. Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 2020;8:E303. [PMID: 32842558 DOI: 10.3390/biomedicines8090303] [Reference Citation Analysis]
31 Cavalcante MB, Cavalcante CTMB, Braga ACS, Andrade DA, Montenegro MA, Santos PAN, Motoyama PVP, Rocha MG, Dib LA, Araujo Júnior E. COVID-19 Treatment: Drug Safety Prior to Conception and During Pregnancy and Breastfeeding. Geburtshilfe Frauenheilkd 2021;81:46-60. [PMID: 33487665 DOI: 10.1055/a-1247-5271] [Reference Citation Analysis]
32 Taylor SK, Houshdaran S, Robinson JF, Gormley MJ, Kwan EY, Kapidzic M, Schilling B, Giudice LC, Fisher SJ. Cytotrophoblast extracellular vesicles enhance decidual cell secretion of immune modulators via TNFα. Development 2020;147:dev187013. [PMID: 32747437 DOI: 10.1242/dev.187013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Sanmartí R, Ruiz-Esquide V, Bastida C, Soy D. Tocilizumab in the treatment of adult rheumatoid arthritis. Immunotherapy 2018;10:447-64. [PMID: 29495891 DOI: 10.2217/imt-2017-0173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
34 D'Souza R, Wuebbolt D, Andrejevic K, Ashraf R, Nguyen V, Zaffar N, Rotstein D, Wyne A. Pregnancy and Neuromyelitis Optica Spectrum Disorder - Reciprocal Effects and Practical Recommendations: A Systematic Review. Front Neurol 2020;11:544434. [PMID: 33178102 DOI: 10.3389/fneur.2020.544434] [Reference Citation Analysis]
35 Roodenrijs NMT, Hamar A, Kedves M, Nagy G, van Laar JM, van der Heijde D, Welsing PMJ. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open 2021;7:e001512. [PMID: 33419871 DOI: 10.1136/rmdopen-2020-001512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Colla L, Diena D, Rossetti M, Manzione AM, Marozio L, Benedetto C, Biancone L. Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. J Nephrol 2018;31:361-83. [DOI: 10.1007/s40620-018-0477-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
37 Scott LJ. Tocilizumab: A Review in Rheumatoid Arthritis. Drugs 2017;77:1865-79. [PMID: 29094311 DOI: 10.1007/s40265-017-0829-7] [Cited by in Crossref: 138] [Cited by in F6Publishing: 124] [Article Influence: 34.5] [Reference Citation Analysis]
38 Prairie E, Côté F, Tsakpinoglou M, Mina M, Quiniou C, Leimert K, Olson D, Chemtob S. The determinant role of IL-6 in the establishment of inflammation leading to spontaneous preterm birth. Cytokine Growth Factor Rev 2021;59:118-30. [PMID: 33551331 DOI: 10.1016/j.cytogfr.2020.12.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Martínez-Sánchez N, De la Calle Fernández-Miranda M, Bartha JL. Safety profile of treatments administered in COVID 19 infection in pregnant women. Clin Invest Ginecol Obstet 2021;48:100663. [PMID: 33654337 DOI: 10.1016/j.gine.2021.01.004] [Reference Citation Analysis]
40 Nguyen H, Ahmed K, Luo W, Flint J, Giles I. A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy. Semin Arthritis Rheum 2021;51:1205-17. [PMID: 34689007 DOI: 10.1016/j.semarthrit.2021.09.004] [Reference Citation Analysis]
41 Nagy G, Roodenrijs NMT, Welsing PMJ, Kedves M, Hamar A, van der Goes MC, Kent A, Bakkers M, Pchelnikova P, Blaas E, Senolt L, Szekanecz Z, Choy EH, Dougados M, Jacobs JW, Geenen R, Bijlsma JW, Zink A, Aletaha D, Schoneveld L, van Riel P, Dumas S, Prior Y, Nikiphorou E, Ferraccioli G, Schett G, Hyrich KL, Mueller-Ladner U, Buch MH, McInnes IB, van der Heijde D, van Laar JM. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 2021:annrheumdis-2021-220973. [PMID: 34407926 DOI: 10.1136/annrheumdis-2021-220973] [Reference Citation Analysis]
42 Cardiel MH, Carrillo S, Pérez M, Andrade L, Pacheco Tena C, Silveira LH, Limón L, Cerpa S, Gutiérrez Ureña S, Durán S, Irazoque Palazuelos F, Muñoz López S, Sicsik Ayala SA, Barile L, Ramos Sánchez MA, Grajeda Portes D, Portela M, Hernández Bedolla A, García-Figueroa JL, Montero M, Abud-Mendoza C, Martínez Martínez MU, Herrera van Ostdam D, Pascual-Ramos V, Merayo-Chalico J, Guzmán-Sánchez I, Pérez-Bastidas ME, Aguilar Arreola JE, López Rodríguez A, Reyes-Cordero G, Ricardez HA, Hernández Cabrera MF, Olvera-Soto G, Xibillé Friedmann D. Update of the Mexican College of Rheumatology Guidelines for the Pharmacological Treatment of Rheumatoid Arthritis, 2018. Reumatol Clin (Engl Ed) 2021;17:215-28. [PMID: 31103432 DOI: 10.1016/j.reuma.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 De Lorenzo R, Ramirez GA, Punzo D, Lorioli L, Rovelli R, Canti V, Barera G, Rovere-Querini P. Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacol Res 2020;152:104583. [PMID: 31816434 DOI: 10.1016/j.phrs.2019.104583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Cox LS, Redman C. The role of cellular senescence in ageing of the placenta. Placenta 2017;52:139-45. [DOI: 10.1016/j.placenta.2017.01.116] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 12.4] [Reference Citation Analysis]
45 Häfeli C, Förger F. [Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding]. Z Rheumatol 2021;80:716-25. [PMID: 34581874 DOI: 10.1007/s00393-021-01095-z] [Reference Citation Analysis]
46 Tada Y, Sakai M, Nakao Y, Maruyama A, Ono N, Koarada S. Placental transfer of tocilizumab in a patient with rheumatoid arthritis. Rheumatology (Oxford) 2019;58:1694-5. [PMID: 31329987 DOI: 10.1093/rheumatology/kez155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
47 Tugizova M, Vlahovic L, Tomczak A, Wetzel NS, Han MH. New Therapeutic Landscape in Neuromyelitis Optica. Curr Treat Options Neurol 2021;23:13. [PMID: 33814893 DOI: 10.1007/s11940-021-00667-3] [Reference Citation Analysis]
48 Zöllkau J, Hagenbeck C, Hecher K, Pecks U, Schlembach D, Simon A, Schlösser R, Schleußner E. [Recommendations for SARS-CoV-2/COVID-19 during Pregnancy, Birth and Childbed - Update November 2021 (Long Version)]. Z Geburtshilfe Neonatol 2021. [PMID: 34918334 DOI: 10.1055/a-1688-9398] [Reference Citation Analysis]
49 San-Juan R, Barbero P, Fernández-Ruiz M, López-Medrano F, Lizasoáin M, Hernández-Jiménez P, Silva JT, Ruiz-Ruigómez M, Corbella L, Rodríguez-Goncer I, Folgueira MD, Lalueza A, Batllori E, Mejía I, Forcén L, Lumbreras C, García-Burguillo A, Galindo A, Aguado JM. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. EClinicalMedicine 2020;23:100407. [PMID: 32632417 DOI: 10.1016/j.eclinm.2020.100407] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
50 Favalli EG, Biggioggero M, Crotti C, Becciolini A, Raimondo MG, Meroni PL. Sex and Management of Rheumatoid Arthritis. Clinic Rev Allerg Immunol 2019;56:333-45. [DOI: 10.1007/s12016-018-8672-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
51 Puchner A, Gröchenig HP, Sautner J, Helmy-Bader Y, Juch H, Reinisch S, Högenauer C, Koch R, Hermann J, Studnicka-Benke A, Weger W, Puchner R, Dejaco C. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.Wien Klin Wochenschr. 2019;131:29-44. [PMID: 30643992 DOI: 10.1007/s00508-019-1448-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
52 Góralczyk A, Kolossa K, Waszczak-Jeka M, Adamczak R, Jeka S. The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation. Postepy Dermatol Alergol 2020;37:306-12. [PMID: 32774212 DOI: 10.5114/ada.2020.96294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, Leite MI, Jarius S, Hellwig K. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nat Rev Neurol 2020;16:154-70. [PMID: 32080393 DOI: 10.1038/s41582-020-0313-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
54 Rezaee H, Pourkarim F, Pourtaghi-Anvarian S, Entezari-Maleki T, Asvadi-Kermani T, Nouri-Vaskeh M. Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview. Pharmacol Res Perspect 2021;9:e00705. [PMID: 33421347 DOI: 10.1002/prp2.705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
55 Katagiri R, Ishihara-hattori K, Frings W, Amano J, Fuchs A, Chiba S. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey: Effects of SA237, IL-6R Blockade, in Cynomolgus Monkey. Birth Defects Research 2017;109:843-56. [DOI: 10.1002/bdr2.1036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Ogata A, Kato Y, Higa S, Yoshizaki K. IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. Mod Rheumatol 2019;29:258-67. [PMID: 30427250 DOI: 10.1080/14397595.2018.1546357] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 17.7] [Reference Citation Analysis]
57 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
58 Jiménez-Lozano I, Caro-Teller JM, Fernández-Hidalgo N, Miarons M, Frick MA, Batllori Badia E, Serrano B, Parramon-Teixidó CJ, Camba-Longueira F, Moral-Pumarega MT, San Juan-Garrido R, Cabañas Poy MJ, Suy A, Gorgas Torner MQ. Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study. J Clin Pharm Ther 2021;46:1062-70. [PMID: 33638257 DOI: 10.1111/jcpt.13394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Gerosa M, Argolini LM, Artusi C, Chighizola CB. The use of biologics and small molecules in pregnant patients with rheumatic diseases. Expert Rev Clin Pharmacol 2018;11:987-98. [PMID: 30227748 DOI: 10.1080/17512433.2018.1525293] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
60 Østensen M. The use of biologics in pregnant patients with rheumatic disease. Expert Rev Clin Pharmacol 2017;10:661-9. [PMID: 28326845 DOI: 10.1080/17512433.2017.1305268] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
61 Nakamura E, Kotani T, Hiramatsu Y, Hata K, Yoshikawa A, Matsumura Y, Tokai N, Wada Y, Fujita D, Takeuchi T. Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis. Mod Rheumatol 2021;31:809-16. [PMID: 32990114 DOI: 10.1080/14397595.2020.1829342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]